Product NDC: | 0009-4709 |
Proprietary Name: | Depo-SubQ Provera |
Non Proprietary Name: | medroxyprogesterone acetate |
Active Ingredient(s): | 104 mg/.65mL & nbsp; medroxyprogesterone acetate |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0009-4709 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021583 |
Marketing Category: | NDA |
Start Marketing Date: | 20050502 |
Package NDC: | 0009-4709-13 |
Package Description: | .65 mL in 1 SYRINGE (0009-4709-13) |
NDC Code | 0009-4709-13 |
Proprietary Name | Depo-SubQ Provera |
Package Description | .65 mL in 1 SYRINGE (0009-4709-13) |
Product NDC | 0009-4709 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | medroxyprogesterone acetate |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20050502 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | MEDROXYPROGESTERONE ACETATE |
Strength Number | 104 |
Strength Unit | mg/.65mL |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |